These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4420 related articles for article (PubMed ID: 6606628)

  • 1. Protein A treatment of cancer: activation of a serum component with trans-species anti-B16 melanoma activity.
    Cooper PD; Masinello GR
    Int J Cancer; 1983 Dec; 32(6):737-44. PubMed ID: 6606628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the first component of complement, C1, by a monoclonal antibody recognizing the C chain of C1q.
    Heinz HP; Burger R; Golan MD; Loos M
    J Immunol; 1984 Feb; 132(2):804-8. PubMed ID: 6606678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of bovine immunoglobulins with complement.
    Sellei J
    Comp Immunol Microbiol Infect Dis; 1987; 10(2):93-8. PubMed ID: 3497768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of C1q by monoclonal antibodies.
    Heinz HP; Loos M
    Behring Inst Mitt; 1984 Nov; (76):42-58. PubMed ID: 6335397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigenic interspecies cross-reaction of subcomponent C1q of the first component of complement: evidence for its cross-reaction in both collagen-like and non-collagen-like regions.
    Yonemasu K; Sasaki T; Shimizu A
    J Biochem; 1983 Apr; 93(4):1079-84. PubMed ID: 6408070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of C1 by monoclonal antibodies directed against C1q.
    Kilchherr E; Schumaker VN; Curtiss LK
    Biochem Biophys Res Commun; 1985 Jan; 126(2):785-91. PubMed ID: 3872122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The subcomponent Clq of the first component of guinea pig complement: purification and characterization.
    Sasaki T; Ueda M; Yonemasu K
    J Immunol Methods; 1982; 48(1):121-31. PubMed ID: 6976996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C1q binding and C1 activation by various isolated cellular membranes.
    Storrs SB; Kolb WP; Olson MS
    J Immunol; 1983 Jul; 131(1):416-22. PubMed ID: 6602834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B16 melanoma in C57BL-6J mice: kinetics and effects of heterologous serum.
    Hill GJ; Littlejohn K
    J Surg Oncol; 1971; 3(1):1-7. PubMed ID: 5093800
    [No Abstract]   [Full Text] [Related]  

  • 11. Purification and characterization of the 1q subcomponent of canine complement and its use in the 125I-C1q binding assay for detection of immune complexes.
    Wu CC; Bey RF; Loken KI
    Am J Vet Res; 1988 Jun; 49(6):865-9. PubMed ID: 3135770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stoichiometry and sedimentation properties of the complex formed between the C1q and C1r2C1s2 subcomponents of the first component of complement.
    Siegel RC; Schumaker VN; Poon PH
    J Immunol; 1981 Dec; 127(6):2447-52. PubMed ID: 6975324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis of the first component of complement by human fibroblasts.
    Reid KB; Solomon E
    Biochem J; 1977 Dec; 167(3):647-60. PubMed ID: 603627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of EDTA and citrate on the functional activity of the first component of complement, C1, and the C1q subcomponent.
    Zapf S; Loos M
    Immunobiology; 1985 Sep; 170(3):123-32. PubMed ID: 3932188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal anti-mouse macrophage antibodies recognize the globular portions of C1q, a subcomponent of the first component of complement.
    Heinz HP; Dlugonska H; Rüde E; Loos M
    J Immunol; 1984 Jul; 133(1):400-4. PubMed ID: 6609989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of C1 activation by a monoclonal anti-C1q antibody and its (Fab)2 fragments.
    Kilchherr E; Schumaker VN; Bianchino AC; Curtiss LK
    J Immunol; 1987 Feb; 138(3):849-55. PubMed ID: 3492535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation and analysis of immune complexes from sera of patients with polymyalgia rheumatica and giant cell arteritis.
    Smith AJ; Kyle V; Cawston TE; Hazleman BL
    Ann Rheum Dis; 1987 Jun; 46(6):468-74. PubMed ID: 2820320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of C1q subcomponent with immunoglobulin M.
    Kimak E; Tomaszewski JJ
    Acta Biochim Pol; 1986; 33(3):179-85. PubMed ID: 2433858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of immune precipitation by purified classical pathway complement components.
    Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
    Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 221.